{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:56Z","timestamp":1781650376528,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Greifswald"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Primary headache disorders, particularly migraine, rank among the leading causes of disability worldwide and impose substantial social and economic burden. Multimodal headache treatment (MMHT) combines pharmacologic, physiotherapeutic and cognitive-behavioural interventions and has shown benefit in high-burden patients, yet the psychological factors associated with sustained improvement remain unclear. Self-efficacy (SE) supports active coping, whereas the chance-related multidimensional health locus of control (CMHLC-C) reflects belief in uncontrollable outcomes. We hypothesised that these control beliefs are modifiable through intervention and that their baseline levels are associated with subsequent improvement in headache burden. Adults with primary headache disorders were enrolled in a prospective observational study and participated in a one-week MMHT at a tertiary neurological day clinic. Headache impact (HIT-6; primary endpoint), monthly headache days (MHD), and highest headache pain severity (HHPS) were measured three months before treatment (waiting-list baseline), at the start and end of MMHT, and at 3-, 6-, and 9-month follow-up. The waiting-list period served as a within-person pre-treatment comparator for spontaneous change. Baseline headache-management SE and MHLC-C subscales were tested as predictors of longitudinal HIT-6 trajectories using a generalized linear mixed model with visit as a repeated factor. Sixty-five patients were included in the analytic cohort (84.6% female; mean age 40.6\u2009\u00b1\u200913.3 years; 89.8% migraine). HIT-6 decreased from 63.2 at the waiting-list baseline to 59.0 at nine months (\n                    <jats:italic>p<\/jats:italic>\n                    &lt;.001). MHD was reduced from 17.9\u2009\u00b1\u20098.0 to 12.2\u2009\u00b1\u20097.5 days, and 44% experienced a\u2009\u2265\u200930% reduction. HHPS also decreased throughout follow-up. Mean SE increased significantly during MMHT and early follow-up, whereas CMHLC-C showed only small changes over time. The mixed model was significant (F(2,165)\u2009=\u20097.25,\n                    <jats:italic>p<\/jats:italic>\n                    &lt;.001). Higher baseline SE predicted larger reductions in HIT-6 (\u03b2=\u22120.55, t(165)\u2009=\u2009\u2212\u20092.62,\n                    <jats:italic>p<\/jats:italic>\n                    =.010), whereas greater belief in chance predicted smaller reductions (\u03b2\u2009=\u20090.85, t(165)\u2009=\u20092.80,\n                    <jats:italic>p<\/jats:italic>\n                    =.006). In this prospective observational study with a waiting-list comparator, MMHT was associated with sustained reductions in headache impact, headache frequency, and pain severity. Baseline self-efficacy and chance-related control beliefs independently predicted treatment response and may represent clinically relevant stratification targets in personalised headache care.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-47295-y","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:18:04Z","timestamp":1776161884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of self-efficacy and control beliefs in response to a multimodal headache intervention: results from a prospective observational study with a waiting-list comparator"],"prefix":"10.1038","volume":"16","author":[{"given":"Luise","family":"Bartsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Fiebig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kl\u00f6tzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Strau\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"47295_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s10194-024-01889-x","volume":"25","author":"A Raggi","year":"2024","unstructured":"Raggi, A. et al. Hallmarks of primary headache: part 1 - migraine. J. Headache Pain. 25 (1), 189 (2024).","journal-title":"J. Headache Pain"},{"issue":"4","key":"47295_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","volume":"81","author":"DC Buse","year":"2010","unstructured":"Buse, D. C., Manack, A., Serrano, D., Turkel, C. & Lipton, R. B. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J. Neurol. Neurosurg. Psychiatry. 81 (4), 428\u2013432 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10258","key":"47295_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396 (10258), 1204\u20131222 (2020).","journal-title":"Lancet"},{"issue":"1","key":"47295_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.genhosppsych.2008.09.006","volume":"31","author":"GE Ratcliffe","year":"2009","unstructured":"Ratcliffe, G. E., Enns, M. W., Jacobi, F., Belik, S. L. & Sareen, J. The relationship between migraine and mental disorders in a population-based sample. Gen. Hosp. Psychiatry. 31 (1), 14\u201319 (2009).","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"9","key":"47295_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.seizure.2011.06.017","volume":"20","author":"N Aydemir","year":"2011","unstructured":"Aydemir, N., Ozkara, C., Unsal, P. & Canbeyli, R. A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine. Seizure 20 (9), 679\u2013685 (2011).","journal-title":"Seizure"},{"issue":"2","key":"47295_CR6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby, P. J. et al. Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol. Rev. 97 (2), 553\u2013622 (2017).","journal-title":"Physiol. Rev."},{"issue":"2","key":"47295_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp042897","volume":"354","author":"DW Dodick","year":"2006","unstructured":"Dodick, D. W. Clinical practice. Chronic daily headache. N. Engl. J. Med. 354 (2), 158\u2013165 (2006).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"47295_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/archinte.159.8.813","volume":"159","author":"XH Hu","year":"1999","unstructured":"Hu, X. H., Markson, L. E., Lipton, R. B., Stewart, W. F. & Berger, M. L. Burden of migraine in the United States: disability and economic costs. Arch. Intern. Med. 159 (8), 813\u2013818 (1999).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"47295_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10194-011-0348-y","volume":"12","author":"C Gaul","year":"2011","unstructured":"Gaul, C. et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J. Headache Pain. 12 (4), 475\u2013483 (2011).","journal-title":"J. Headache Pain"},{"issue":"7","key":"47295_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10194-012-0469-y","volume":"13","author":"TM Wallasch","year":"2012","unstructured":"Wallasch, T. M. & Kropp, P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J. Headache Pain. 13 (7), 521\u2013529 (2012).","journal-title":"J. Headache Pain"},{"issue":"5","key":"47295_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10194-011-0364-y","volume":"12","author":"C Gaul","year":"2011","unstructured":"Gaul, C. et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J. Headache Pain. 12 (5), 511\u2013519 (2011).","journal-title":"J. Headache Pain"},{"issue":"7","key":"47295_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1526-4610.2003.03128.x","volume":"43","author":"LH Harpole","year":"2003","unstructured":"Harpole, L. H. et al. Headache management program improves outcome for chronic headache. Headache 43 (7), 715\u2013724 (2003).","journal-title":"Headache"},{"key":"47295_CR13","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38 (1), 1\u2013211 (2018).","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"47295_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12160-010-9223-3","volume":"40","author":"EK Seng","year":"2010","unstructured":"Seng, E. K. & Holroyd, K. A. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann. Behav. Med. 40 (3), 235\u2013247 (2010).","journal-title":"Ann. Behav. Med."},{"key":"47295_CR15","doi-asserted-by":"crossref","unstructured":"Bae, J. Y. et al. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Med. (Kaunas) 58(1). (2021).","DOI":"10.3390\/medicina58010044"},{"issue":"3","key":"47295_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0333102410379890","volume":"31","author":"M Yang","year":"2011","unstructured":"Yang, M., Rendas-Baum, R., Varon, S. F. & Kosinski, M. Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine. Cephalalgia 31 (3), 357\u2013367 (2011).","journal-title":"Cephalalgia"},{"issue":"5","key":"47295_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1526-4610.2005.05094.x","volume":"45","author":"F Andrasik","year":"2005","unstructured":"Andrasik, F., Lipchik, G. L., McCrory, D. C. & Wittrock, D. A. Outcome measurement in behavioral headache research: headache parameters and psychosocial outcomes. Headache 45 (5), 429\u2013437 (2005).","journal-title":"Headache"},{"key":"47295_CR18","doi-asserted-by":"crossref","unstructured":"Graef, J. E. et al. G erman Language Adaptation of the H eadache M anagement S elf-Efficacy S cale (HMSE\u2010G) and Development of a New Short Form (HMSE\u2010G\u2010SF). 55(7) 958\u2013972. (2015).","DOI":"10.1111\/head.12564"},{"issue":"2","key":"47295_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/109019817800600107","volume":"6","author":"KA Wallston","year":"1978","unstructured":"Wallston, K. A., Wallston, B. S. & DeVellis, R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ. Monogr. 6 (2), 160\u2013170 (1978).","journal-title":"Health Educ. Monogr."},{"key":"47295_CR20","doi-asserted-by":"crossref","unstructured":"Bartsch, L. et al. Translation of Multidimensional Health Locus of Control Scales, Form C in Patients with Headache. J. Clin. Med. ;13(14). (2024).","DOI":"10.3390\/jcm13144239"},{"issue":"7","key":"47295_CR21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1526-4610.2012.02189.x","volume":"52","author":"TM Wallasch","year":"2012","unstructured":"Wallasch, T. M., Angeli, A. & Kropp, P. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache 52 (7), 1094\u20131105 (2012).","journal-title":"Headache"},{"issue":"1","key":"47295_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s10194-023-01587-0","volume":"24","author":"SJ Tepper","year":"2023","unstructured":"Tepper, S. J. et al. The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression. J. Headache Pain. 24 (1), 54 (2023).","journal-title":"J. Headache Pain"},{"issue":"1","key":"47295_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2005","unstructured":"Barnett, A. G., van der Pols, J. C. & Dobson, A. J. Regression to the mean: what it is and how to deal with it. Int. J. Epidemiol. 34 (1), 215\u2013220 (2005).","journal-title":"Int. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47295-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:01:01Z","timestamp":1781647261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47295-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of University Medicine Greifswald (Ethikkommission an der Universit\u00e4tsmedizin Greifswald; approval number: BB 004\/21, 02\/02\/2021). All participants provided written informed consent prior to enrollment. All procedures adhered to the Declaration of Helsinki and relevant local regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"12359"}}